List of Tables - Pulmonary Arterial Hypertension (PAH) Treatment Market Expected to Grow at 7.6% by 2032

Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class (Endothelin Receptor Antagonists (ERAs), Vasodilators, Phosphodiesterase-5 (PDE-5) Inhibitors, Soluble Guanylate Cyclase (sGC) Stimulators, Calcium Channel Blockers (CCBs), Others) - Growth, Future Prospects & Competitive Analysis, 2025 – 2033

24 Sep 2018 Format

TABLE 1 Global Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 2 North America Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 3 U.S. Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 4 Canada Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 5 Rest of North America Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 6 UK and European Union Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 7 UK Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 8 Germany Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 9 Spain Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 10 Italy Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 11 France Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 12 Rest of Europe Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 13 Asia Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 14 China Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 15 Japan Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 16 India Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 17 Australia Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 18 South Korea Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 19 Latin America Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 20 Brazil Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 21 Mexico Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 22 Rest of Latin America Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 23 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 24 GCC Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 25 Africa Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)
TABLE 26 Rest of Middle East and Africa Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class, 2023-2033, USD (Million)